.jpg)
STAT Plus: Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort
Good morning, everyone, and nice to see you again. We have returned, so to speak,…
Category: opioids
FDA says opioid labels must include information about naloxone
WASHINGTON — The Food and Drug Administration announced Thursday that it would require drug manufacturers…
Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets
WASHINGTON — Drug overdoses have skyrocketed and demand for addiction treatment medicine has soared as…
STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals
And so, another working week will soon draw to a close. If you are surprised…
STAT Plus: Pharmalittle: Glaxo aims for 1 billion doses of a Covid-19 vaccine booster; Pence aide holds lots of pharma stocks
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: Pharmalittle: Merck enters Covid-19 vaccine race; pharma alarmed by push for U.S.-only supply chain
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Real-time data are essential for Covid-19. They’re just as important for the opioid overdose crisis
As the Covid-19 epidemic sweeps across the country leaving death and confusion in its wake,…
STAT Plus: Pharmalittle: Sanofi walks back Covid-19 vaccine remarks; Trump to name vaccine czar with conflicts
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
CVS long-term care pharmacy pays $15 million penalty for failing to track opioids
Omnicare, which is the largest long-term care pharmacy in the U.S., agreed to pay a…
Covid-19 has streamlined addiction medicine. Will the changes stick?
Nicole Godinez’s monthly visit to an addiction clinic typically takes several hours: To start, there’s…
STAT Plus: Pharmalittle: Gilead faces remdesivir production challenges; will scientists run out of Covid-19 trial patients?
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Trump tones down hydroxycholoroquine hype; U.N. resolution calls for access to Covid-19 products
Good morning, everyone, and how are you today? We are doing okay, thank you, given…
STAT Plus: Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend offered something…
STAT Plus: Pharmalittle: More than one coronavirus vaccine may be needed; Utah bill would protect docs prescribing meds for Covid-19
Hello, everyone, and how are you today? We are coping, thank you, despite the ongoing…
STAT Plus: Pharmacy chains gain a ‘solid’ victory in opioid litigation, but aren’t off the hook yet
As jockeying in the opioid litigation continues, a U.S. appeals court ruled several large pharmacy…
Methadone clinic lines and packed waiting rooms leave clients vulnerable to the coronavirus
One photo shows a long line of people standing close together while waiting for methadone…
STAT Plus: Opioid-overdose prescriptions may go unfilled due to the cost
Although naloxone is widely regarded as an effective antidote for reversing opioid overdoses, a new…
Opinion: Covid-19 will worsen the opioid overdose crisis if we don’t prepare now
In cities across the country, morning is peak time at almost any opioid treatment program….
Opinion: I thought I understood the Sacklers’ opioid empire. Startling documents from a whistleblower and declassified government files proved me wrong
What could possibly be new about the Sackler family, the billionaire owners of Purdue Pharma?…
STAT Plus: California slams AmerisourceBergen over opioid shipments to pharmacies
The California Board of Pharmacy cancelled a wholesale license for AmerisourceBergen (ABC) and fined the…
STAT Plus: Alkermes sued over death of man who overdosed after taking addiction treatment Vivitrol
The parents of a 26-year-old California man who died of an opioid overdose have sued…
STAT Plus: Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison
The founder of a biotech who said his company had developed a painkiller that would…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: As opioid crisis intensified, many family doctors found promotional pitches were very good
As the opioid crisis accelerated a decade ago, pharmaceutical sales reps emphasized the benefits of…
Opinion: What an 1890s opioid epidemic can teach us about ending addiction today
In the ’90s, chronic pain was rampant in America. Opioids, which had previously been taboo,…
STAT Plus: California scolds McKesson for supplying excessive controlled substances to a children’s pharmacy
The California Board of Pharmacy is accusing McKesson (MCK), the large pharmaceutical wholesaler, of selling…
STAT Plus: Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
Federal prosecutors this week announced a $145 million settlement with an electronic health records company…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
STAT Plus: McKesson reaches $175 million deal with shareholders over lax oversight of opioid shipments
As pressure mounts on pharmaceutical wholesalers over their role in the opioid crisis, McKesson (MCK)…
STAT Plus: Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme
The founder of Insys Therapeutics was sentenced to 5½ years in federal prison Thursday for…
STAT Plus: Former Insys executive sentenced to a year and a day for her role in opioid bribery scheme
A former pharmaceutical executive and one-time stripper was sentenced to a year and a day…
STAT Plus: Pharmalittle: FTC member favors Medicare negotiation on drug prices; BioMarin weighs pricing world’s most expensive drug
Good morning. Elizabeth Cooney here again, channeling Ed Silverman as another week draws to a…
STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?
Good morning. Elizabeth Cooney here in Boston while Ed Silverman hobnobs with industry types at…
Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
PIKEVILLE, Ky. — A year and a half after the opioid painkiller OxyContin went on…
STAT Plus: Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: Pharmalittle: FDA failed to police opioid prescribing program; Novo launches plan to mitigate insulin cost
Good morning, everyone, and welcome to a new year. We hope the extended respite —…
STAT Plus: Crash and burn: The four biggest biopharma failures of 2019
In biotech, companies fail for a lot of reasons. The science might not quite work,…
STAT Plus: Prosecutors seek a 15-year jail sentence for former Insys CEO for his role in the opioid crisis
For his role in fomenting the opioid crisis, federal officials want to sentence Insys Therapeutics…
Purdue, maker of OxyContin, quietly splits ways with PhRMA as it pulls back from lobbying
WASHINGTON — Purdue Pharma, the embattled opioid maker, has quietly split ways with PhRMA, the…
The history of OxyContin, told through unsealed Purdue documents
PIKEVILLE, Ky. — STAT’s multiyear legal battle to unseal secret Purdue Pharma files in a…
Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show
PIKEVILLE, Ky. — In the early days of OxyContin, Dr. Richard Sackler, a member of…
STAT Plus: Pharmalittle: Feds probe drug makers for flooding communities with opioids; States proceeding with importation
And so, another working week will soon come to an end, but earlier than usual,…
Opinion: Changing emergency doctors’ behaviors to promote wider use of medication for opioid use disorder
Emergency departments have become the front line in the battle against the epidemic of opioid…
OxyContin maker thrives in China with abandoned U.S. tactics
SHANGHAI — OxyContin is a dying business in the United States. Purdue Pharma, owned by…
STAT Plus: Pharmalittle: How Purdue planted its ‘anti-story’; how much does that ‘free’ flu shot cost?
Good morning. Elizabeth Cooney here again in Boston while Ed Silverman completes another engagement abroad….
How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic
This story is a collaboration between STAT and ProPublica. In 2004, Purdue Pharma was facing…